Style | Citing Format |
---|---|
MLA | Salehi AM, et al.. "Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2)." Pharmaceutical Research, vol. 40, no. 2, 2023, pp. 615-616. |
APA | Salehi AM, Hajizadeh F, Barshidi A, Rashidi B, Ebrahimi F, Bahmanpour S, Karpisheh V, Noukabadi FK, Kiani FK, Hassannia H, Atyabi F, Kiaie SH, Kashanchi F, Navashenaq JG, Mohammadi H, Bagherifar R, Jafari R, Zolbanin NM, Jadidiniaragh F (2023). Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2). Pharmaceutical Research, 40(2), 615-616. |
Chicago | Salehi AM, Hajizadeh F, Barshidi A, Rashidi B, Ebrahimi F, Bahmanpour S, Karpisheh V, et al.. "Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2)." Pharmaceutical Research 40, no. 2 (2023): 615-616. |
Harvard | Salehi AM et al. (2023) 'Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2)', Pharmaceutical Research, 40(2), pp. 615-616. |
Vancouver | Salehi AM, Hajizadeh F, Barshidi A, Rashidi B, Ebrahimi F, Bahmanpour S, et al.. Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2). Pharmaceutical Research. 2023;40(2):615-616. |
BibTex | @article{ author = {Salehi AM and Hajizadeh F and Barshidi A and Rashidi B and Ebrahimi F and Bahmanpour S and Karpisheh V and Noukabadi FK and Kiani FK and Hassannia H and Atyabi F and Kiaie SH and Kashanchi F and Navashenaq JG and Mohammadi H and Bagherifar R and Jafari R and Zolbanin NM and Jadidiniaragh F}, title = {Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2)}, journal = {Pharmaceutical Research}, volume = {40}, number = {2}, pages = {615-616}, year = {2023} } |
RIS | TY - JOUR AU - Salehi AM AU - Hajizadeh F AU - Barshidi A AU - Rashidi B AU - Ebrahimi F AU - Bahmanpour S AU - Karpisheh V AU - Noukabadi FK AU - Kiani FK AU - Hassannia H AU - Atyabi F AU - Kiaie SH AU - Kashanchi F AU - Navashenaq JG AU - Mohammadi H AU - Bagherifar R AU - Jafari R AU - Zolbanin NM AU - Jadidiniaragh F TI - Retraction Note: Combination Cancer Immunotherapy With Dendritic Cell Vaccine and Nanoparticles Loaded With Interleukin-15 and Anti-Beta-Catenin Sirna Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/S11095-022-03169-2) JO - Pharmaceutical Research VL - 40 IS - 2 SP - 615 EP - 616 PY - 2023 ER - |